Finance

Lists
HRTIS:HEL
Herantis Pharma Oyj
€1,34
-0,45%
(-0,0060) 1D
8 Okt., 18:29:58 GMT+3  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for HRTIS...
Open
€1,42
High
€1,42
Low
€1,33
Mkt. cap
34,69 m
Avg. vol.
24,22 k
Volume
11,67 k
52-wk high
€3,87
52-wk low
€1,32
EPS
-€0,28
Shares outstanding
26,50 m
No. of employees
14
Open
€1,42
High
€1,42
Low
€1,33
Mkt. cap
34,69 m
Avg. vol.
24,22 k
Volume
11,67 k
52-wk high
€3,87
52-wk low
€1,32
EPS
-€0,28
Shares outstanding
26,50 m
No. of employees
14
News stories
From web sources and news partners
About Herantis Pharma Oyj
CEOAntti Vuolanto
Employees14
Founded2008
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
402,99 k
402,99 k
585,00 k
585,00 k
Operating expense
1,72 m
1,72 m
1,53 m
1,53 m
Total operating expenses
1,72 m
1,72 m
1,53 m
1,53 m
Operating income
-1,72 m
-1,72 m
-1,53 m
-1,53 m
Other non operating income
-150,07 k
-150,07 k
15,00 k
15,00 k
EBT including unusual items
-1,71 m
-1,71 m
-1,66 m
-1,66 m
EBT excluding unusual items
-1,71 m
-1,71 m
-1,66 m
-1,66 m
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
1,32 m
1,32 m
946,50 k
946,50 k
Net income
-1,71 m
-1,71 m
-1,66 m
-1,66 m
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
160,84 k
160,84 k
3,50 k
3,50 k
Interest expense
-
-
-149,00 k
-149,00 k
Net interest expenses
160,84 k
160,84 k
-145,50 k
-145,50 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme